Several new antibiotic agents for urinary tract infections include β-lactam/β-lactamase inhibitor combinations with cephalosporins and carbapenems. Siderophore cephalosporins, novel aminoglycosides, fluoroquinolones, and tetracyclines are also in clinical development. Nevertheless, antimicrobial stewardship remains important in preserving the utility of the antibiotic agents currently available.
European urology focus. 2018 Dec 13 [Epub ahead of print]
Kurt G Naber, Florian M E Wagenlehner
Department of Urology, Technical University of Munich, Munich, Germany. Electronic address: ., Clinic for Urology, Pediatric Urology and Andrology, Justus Liebig University, Giessen, Germany.